KWM
ALZN icon

KMT Wealth Management’s Alzamend Neuro ALZN Stock Holding History

KMT Wealth Management’s Portfolio ALZN Stock Details ALZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.59M Buy
+1,329,100
New +$1.47M 1.35% 18

Other funds holding ALZN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.98% 1-Year Est. Return
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return

KMT Wealth Management's ALZN Position: Q2 2026 in Review

KMT Wealth Management opened a new position in Alzamend Neuro (ALZN) in Q2 2026: 1,329,100 shares worth $1.59M. The stake represents 1.35% of the portfolio and ranks #18 among its holdings.

5 funds tracked by Wall St. Rank hold ALZN as of Q2 2026.

  • KMT Wealth Management held 1,329,100 shares of Alzamend Neuro worth $1.59M as of Q2 2026.
  • Alzamend Neuro was a new KMT Wealth Management position in Q2 2026.
  • Alzamend Neuro made up 1.35% of KMT Wealth Management's portfolio in Q2 2026, its #18 holding.
  • 5 funds tracked by Wall St. Rank held Alzamend Neuro as of Q2 2026.

Based on KMT Wealth Management's 13F filing for Q2 2026, filed 5 Aug 2026.